# University Hospital Bispebjerg and Frederiksberg

Organization · id `cardio:org-university-hospital-bispebjerg-and-frederiksberg` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=University+Hospital+Bispebjerg+and+Frederiksberg>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: University Hospital Bispebjerg and Frederiksberg
- Sponsor class: OTHER

## Connected pages

- Sponsors: Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements (`cardio:ct-nct02714907`)
- Sponsors: Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (`cardio:ct-nct03778554`)
- Sponsors: Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (`cardio:ct-nct04088292`)
- Sponsors: The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure (`cardio:ct-nct05042973`)
- Sponsors: The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure (`cardio:ct-nct05084235`)
- Sponsors: DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease (`cardio:ct-nct07795398`)

## Provenance

Content hash: b71de345a0f502e6e8f27d859a888d961b47b63fdbdccbe5a611c69a3cd7753f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
